cellaca plx high-throughput image cytometer (Revvity)
Structured Review
Cellaca Plx High Throughput Image Cytometer, supplied by Revvity, used in various techniques. Bioz Stars score: 93/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cellaca+plx/Cellaca+PLX+High-throughput+image+cytometer/custom%40plx-sys1%4010%2E64898%2F2026%2E05%2E11%2E724381
Average 93 stars, based on 23 article reviews
Images
Related Articles
Transmission Assay:Article Title: Cellaca® PLX image cytometer as an alternative for immunophenotyping, GFP/RFP transfection efficiencies, and apoptosis analysis. Article Snippet: Cell and gene therapy is a fast-growing field for cancer therapeutics requiring reliable instrumentation and technologies.. Key parameters essential for satisfying Chemistry Manufacturing and Controls criteria standards are routinely performed using flow cytometry.. Recently, image cytometry was developed for cell characterization and cell-based assays but had not yet demonstrated sufficient sensitivity for surface marker detection. Multiplex Assay:Article Title: A Multiplex Assay to Simultaneously Monitor Apoptosis and Necrosis Using the Cellaca® PLX Image Cytometer. Article Snippet: change in pH) or internal (i.e., oxidative stress, DNA damage, hypoxia) factors [1, 2].. External factors trigger the extrinsic pathway, commonly called the death receptor pathway and are responsible for initiating the apoptotic cascade [3].. The extrinsic pathway binds ligands to death receptors (DR) (members of the tumor necrosis factor (TNF) gene superfamily) on the cell surface [4]. Apoptosis Assay:Article Title: A Multiplex Assay to Simultaneously Monitor Apoptosis and Necrosis Using the Cellaca® PLX Image Cytometer. Article Snippet: change in pH) or internal (i.e., oxidative stress, DNA damage, hypoxia) factors [1, 2].. External factors trigger the extrinsic pathway, commonly called the death receptor pathway and are responsible for initiating the apoptotic cascade [3].. The extrinsic pathway binds ligands to death receptors (DR) (members of the tumor necrosis factor (TNF) gene superfamily) on the cell surface [4]. Cytometry:Article Title: A Multiplex Assay to Simultaneously Monitor Apoptosis and Necrosis Using the Cellaca® PLX Image Cytometer. Article Snippet: change in pH) or internal (i.e., oxidative stress, DNA damage, hypoxia) factors [1, 2].. External factors trigger the extrinsic pathway, commonly called the death receptor pathway and are responsible for initiating the apoptotic cascade [3].. The extrinsic pathway binds ligands to death receptors (DR) (members of the tumor necrosis factor (TNF) gene superfamily) on the cell surface [4]. Article Title: A rapid and high-throughput T cell immunophenotyping assay for cellular therapy bioprocess using the Cellaca® PLX image cytometer. Article Snippet: In cellular therapies chimeric antigen receptor (CAR) T or NK cells undergo phenotypic analysis at multiple stages during discovery and development of novel therapies.. Patient samples are routinely analyzed via flow cytometry for population identification and distribution of CD3, CD4, and CD8 positive T cells.. As an alternative or orthogonal method, image cytometry systems have been used to perform simple cell-based assays in lieu of flow cytometry. Marker:Article Title: A Multiplex Assay to Simultaneously Monitor Apoptosis and Necrosis Using the Cellaca® PLX Image Cytometer. Article Snippet: change in pH) or internal (i.e., oxidative stress, DNA damage, hypoxia) factors [1, 2].. External factors trigger the extrinsic pathway, commonly called the death receptor pathway and are responsible for initiating the apoptotic cascade [3].. The extrinsic pathway binds ligands to death receptors (DR) (members of the tumor necrosis factor (TNF) gene superfamily) on the cell surface [4]. Cell Counting:Article Title: A rapid and high-throughput T cell immunophenotyping assay for cellular therapy bioprocess using the Cellaca® PLX image cytometer. Article Snippet: In cellular therapies chimeric antigen receptor (CAR) T or NK cells undergo phenotypic analysis at multiple stages during discovery and development of novel therapies.. Patient samples are routinely analyzed via flow cytometry for population identification and distribution of CD3, CD4, and CD8 positive T cells.. As an alternative or orthogonal method, image cytometry systems have been used to perform simple cell-based assays in lieu of flow cytometry. Transfection:Article Title: A rapid and high-throughput T cell immunophenotyping assay for cellular therapy bioprocess using the Cellaca® PLX image cytometer. Article Snippet: In cellular therapies chimeric antigen receptor (CAR) T or NK cells undergo phenotypic analysis at multiple stages during discovery and development of novel therapies.. Patient samples are routinely analyzed via flow cytometry for population identification and distribution of CD3, CD4, and CD8 positive T cells.. As an alternative or orthogonal method, image cytometry systems have been used to perform simple cell-based assays in lieu of flow cytometry. Concentration Assay:Article Title: A rapid and high-throughput T cell immunophenotyping assay for cellular therapy bioprocess using the Cellaca® PLX image cytometer. Article Snippet: In cellular therapies chimeric antigen receptor (CAR) T or NK cells undergo phenotypic analysis at multiple stages during discovery and development of novel therapies.. Patient samples are routinely analyzed via flow cytometry for population identification and distribution of CD3, CD4, and CD8 positive T cells.. As an alternative or orthogonal method, image cytometry systems have been used to perform simple cell-based assays in lieu of flow cytometry. Staining:Article Title: A rapid and high-throughput T cell immunophenotyping assay for cellular therapy bioprocess using the Cellaca® PLX image cytometer. Article Snippet: In cellular therapies chimeric antigen receptor (CAR) T or NK cells undergo phenotypic analysis at multiple stages during discovery and development of novel therapies.. Patient samples are routinely analyzed via flow cytometry for population identification and distribution of CD3, CD4, and CD8 positive T cells.. As an alternative or orthogonal method, image cytometry systems have been used to perform simple cell-based assays in lieu of flow cytometry. |
